Search results for "Cost-effectiveness Analysis"

showing 10 items of 32 documents

A Bayesian cost-effectiveness analysis of a telemedicine-based strategy for the management of sleep apnoea: a multicentre randomised controlled trial

2015

Background Compliance with continuous positive airway pressure (CPAP) therapy is essential in patients with obstructive sleep apnoea (OSA), but adequate control is not always possible. This is clinically important because CPAP can reverse the morbidity and mortality associated with OSA. Telemedicine, with support provided via a web platform and video conferences, could represent a cost-effective alternative to standard care management. Aim To assess the telemedicine impact on treatment compliance, cost-effectiveness and improvement in quality of life (QoL) when compared with traditional face-to-face follow-up. Methods A randomised controlled trial was performed to compare a telemedicine-bas…

Pulmonary and Respiratory MedicineMaleTelemedicinemedicine.medical_specialtyEpidemiologymedicine.medical_treatmentCost-Benefit Analysislaw.inventionIndirect costsClinical trialsQuality of lifeRandomized controlled triallawmedicineHumansContinuous positive airway pressureProspective StudiesDisease management (health)EpidemiologiaTelecommunication in medicineSleep apnea syndromesPrimary health careSleep Apnea ObstructiveContinuous Positive Airway Pressurebusiness.industryDisease ManagementBayes TheoremCost-effectiveness analysisSíndromes d'apnea del sonMiddle AgedTelemedicinenervous system diseasesrespiratory tract diseasesClinical trialAtenció primàriaPhysical therapyQuality of LifePatient ComplianceFemalebusinessSleepFollow-Up StudiesTelecomunicació en medicinaAssaigs clínics
researchProduct

Cost-Effectiveness Analysis of Different Testing Strategies that Use Antibody Levels to Detect Chronic Hepatitis C in Blood Donors.

2016

Aim. We conducted a cost-effectiveness analysis of seven hepatitis C virus (HCV) testing strategies in blood donors. Methods. Three of the seven strategies were based on HCV diagnosis and reporting guidelines in Mexico and four were from previous and current recommendations outlined by the CDC. The strategies that were evaluated determine antibody levels according to the signal-to-cut-off (S/CO) ratio and use reflex Immunoblot (IMB) or HCV RNA tests to confirm true positive (TP) cases of chronic HCV infection. Costs were calculated from the perspective of the Mexican Institute of Social Security (IMSS). A decision tree model was developed to estimate the expected number of true positive cas…

RNA virusesDecision AnalysisPhysiologyEconomicsCost-Benefit AnalysisSocial Scienceslcsh:MedicineBlood DonorsHepacivirusmedicine.disease_causeBiochemistryHepatitis0302 clinical medicineImmune Physiology030212 general & internal medicineChroniclcsh:SciencePathology and laboratory medicinehealth care economics and organizationsMultidisciplinaryImmune System ProteinsCost–benefit analysisHepatitis C virusLiver DiseaseCost-effectiveness analysisMedical microbiologyHepatitis CHCV AntibodyInfectious DiseasesVirusesEngineering and TechnologyBlood Banks030211 gastroenterology & hepatologyPathogensInfectionManagement EngineeringResearch Articlemedicine.medical_specialtyGeneral Science & TechnologyHepatitis C virusImmunologyCost-Effectiveness AnalysisImmunoblottingChronic Liver Disease and CirrhosisMolecular Probe TechniquesAntibody levelResearch and Analysis MethodsMicrobiologyAntibodies03 medical and health sciencesChronic hepatitisHepatitis - CClinical ResearchInternal medicineparasitic diseasesmedicineHumansImmunoassaysMolecular Biology TechniquesSensitivity analysesMolecular BiologyMedicine and health sciencesBiology and life sciencesFlavivirusesbusiness.industryDecision Treeslcsh:RHepatitis C antibodyOrganismsViral pathogensProteinsHepatitis C ChronicHepatitis C AntibodiesHepatitis virusesEconomic AnalysisMicrobial pathogensHealth CareEmerging Infectious DiseasesCost Effectiveness ResearchHealth Care FacilitiesImmunologyImmunologic Techniqueslcsh:QbusinessDigestive Diseases
researchProduct

The quality of reporting methods and results of cost-effectiveness analyses in Spain: a methodological systematic review

2016

Open Access; Open Peer Review.-- et al.

Research designCost effectivenessCost-Benefit AnalysisMEDLINEMedicine (miscellaneous)030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineCentre for Reviews and DisseminationEnvironmental healthHumansMedicineQuality-adjusted life years030212 general & internal medicineProtocol (science)Cost–utility analysisbusiness.industryResearchCost-effectiveness analysisCost-utility analysisMethodologyCost-effectiveness analysis3. Good healthQuality-adjusted life yearReportingResearch DesignSpainbusinessDelivery of Health CareSystematic Reviews
researchProduct

Screening for Early Detection of Asymptomatic Coronary Artery Disease (Secondary Prevention): An Approach to Cost/Benefit and Cost/Effectiveness Anal…

1983

Classification of different types of preventive measures for ischemic heart disease (IHD) has been much debated. In the classical use of terms “primary prevention” (prevention of occurrence) includes removal of risk factors in otherwise healthy individuals, while the attempts to change diet and life style in the very early age, in order to avoid the acquisition of risk factors, has been called “preprimary prevention” or “early prevention.”

Secondary preventionmedicine.medical_specialtybusiness.industryEarly detectionCost-effectiveness analysisDiseasemedicine.diseaseAsymptomaticCoronary artery diseaseInternal medicinemedicineCardiologyCost benefitmedicine.symptomIntensive care medicineIschemic heartbusiness
researchProduct

PGI19 Stress Ulcer Bleeding Prophylaxis with Proton Pump Inhibitors, H2 Receptor Antagonists or Sucralfate: A Cost-Effectiveness Analysis

2011

SucralfateHistamine H2 receptorbusiness.industryAnesthesiaStress ulcerHealth PolicyPublic Health Environmental and Occupational HealthMedicineCost-effectiveness analysisbusinessmedicine.diseasehealth care economics and organizationsmedicine.drugValue in Health
researchProduct

Cost effectiveness analysis of childhood obesity primary prevention programmes: a systematic review

2022

Background. Childhood obesity is associated with enormous health consequences and costs to society. This study aims to systematically review the studies on Cost Effectiveness Analysis (CEA) of primary prevention programmes of childhood obesity, discussing the gaps and providing recommendations for future research. Methods. All the studies on the cost effectiveness evaluation of primary prevention of obesity among children were included. Studies were retrieved from MEDLINE and Google Scholar, up to 31st March 2012, with only English language papers being eligible. The quality of the retrieved studies was evaluated by using the Drummond scale. Re…

medicine.medical_specialtyCost effectivenessprimary preventionAlternative medicineMEDLINEsystemic reviewOverweightSettore MED/42 - Igiene Generale E ApplicataChildhood obesityIntervention (counseling)medicineoverweightcost-effectivenesslcsh:R5-920business.industrylcsh:Public aspects of medicinelcsh:RA1-1270Cost-effectiveness analysismedicine.diseaseScale (social sciences)Family medicinePhysical therapymedicine.symptombusinesslcsh:Medicine (General)childhood obesitycost-effectiveness childhood obesity overweight primary prevention systemic reviewEpidemiology Biostatistics and Public Health
researchProduct

Closed Incision Negative Pressure Therapy Achieves Better Outcome Than Standard Wound Care: Clinical Outcome and Cost-Effectiveness Analysis in Open …

2020

BackgroundSurgical site infections (SSIs) and surgical site occurrences (SSOs) are frequent post-operative complications that are dependent on the presence of different risk factors. The use of closed incision negative pressure therapy (ciNPT) is considered a measure by the WHO guidelines for prevention of SSIs. The prevention of SSOs is an extremely important issue in the ventral hernia repair (VHR) surgical field. SSO onset not only affects the patient's quality of life, but can also cause the onset of life-threatening conditions that may require re-hospitalization, re-intervention and often mesh removal. Such outcome can become extremely costly, contributing to increased health care cost…

medicine.medical_specialtyCost effectivenessventral hernia repair030204 cardiovascular system & hematology03 medical and health sciencesWound care0302 clinical medicineQuality of lifeEpidemiologyMedicineguidelinescost-effectivenesssurgical site occurrencesbusiness.industryMedical recordGeneral Engineeringsurgical site infectionsCost-effectiveness analysisabdominal surgeryQuality ImprovementSurgeryRelative riskGeneral Surgeryoutcomeclosed incision negative pressure therapyPreventive Medicinebusiness030217 neurology & neurosurgeryAbdominal surgery
researchProduct

Cost-effectiveness analysis of robot-assisted vs. open partial nephrectomy

2017

Background The cost-effectiveness of robot-assisted partial nephrectomy (RAPN) vs. the open procedure is not established. Methods We estimated in-hospital complications and the cost of RAPN vs. open partial nephrectomy (OPN) using an economic model. Costs incurred both intraoperatively and in hospital were considered. US data were extracted from existing literature. Results Mean in-hospital costs were $14,824 (95% CI $13,368-$16,898) for RAPN and $15,094 (95% CI $13,491-$17,140) for OPN. Complications after RAPN occurred in 23.3% (95% CI 20.0-25.8%) and after OPN in 36.1% (95% CI 35.6-36.6%) of the patients. In a sensitivity analysis, limited centre experience was associated with relevant i…

medicine.medical_specialtyCost-Benefit Analysismedicine.medical_treatment030232 urology & nephrologyBiophysicsNephrectomy03 medical and health sciencesPostoperative Complications0302 clinical medicineRobotic Surgical ProceduresmedicineHumansOpen partial nephrectomyHospital CostsComputer-assisted surgerybusiness.industryDecision TreesPerioperativeCost-effectiveness analysisNephrectomyComputer Science ApplicationsSurgeryModels EconomicTreatment Outcome030220 oncology & carcinogenesisSurgeryLower costbusinessThe International Journal of Medical Robotics and Computer Assisted Surgery
researchProduct

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart diseas…

2013

AIMS: The first aim was to critically evaluate the extent to which familial hypercholesterolaemia (FH) is underdiagnosed and undertreated. The second aim was to provide guidance for screening and treatment of FH, in order to prevent coronary heart disease (CHD).METHODS AND RESULTS: Of the theoretical estimated prevalence of 1/500 for heterozygous FH, <1% are diagnosed in most countries. Recently, direct screening in a Northern European general population diagnosed approximately 1/200 with heterozygous FH. All reported studies document failure to achieve recommended LDL cholesterol targets in a large proportion of individuals with FH, and up to 13-fold increased risk of CHD. Based on prev…

medicine.medical_specialtyStatinAtherosclerosis; Cardiovascular disease; Cholesterol; Coronary heart disease; Low-density lipoproteinSettore MED/09 - Medicina Internamedicine.drug_classPopulationCHILDRENFamilial hypercholesterolemiaBile acid bindingCOST-EFFECTIVENESS ANALYSIS030204 cardiovascular system & hematologyLDL-CHOLESTEROLDIAGNOSIS03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEzetimibeInternal medicineDiabetes mellitusmedicineMANAGEMENT030212 general & internal medicineeducationHealth aging / healthy living Cardiovascular diseases [IGMD 5]Alirocumabeducation.field_of_studyCYTOKINE PATTERN CHANGEbusiness.industryLow-density lipoproteinmedicine.diseaseAtherosclerosisCardiovascular diseaseLomitapideDENSITY-LIPOPROTEIN APHERESIS3. Good healthASSOCIATION EXPERT PANELCoronary heart diseaseEndocrinologyCholesterolchemistryCARDIOVASCULAR-DISEASEAtherosclerosiCardiology and Cardiovascular MedicinebusinessSTATIN TREATMENTmedicine.drugEuropean Heart Journal
researchProduct

Efficiency of telemedicine for acute stroke: a cost-effectiveness analysis from a French pilot study

2020

AbstractObjectivesTelestroke is an effective way to improve care and health outcomes for stroke patients. This study evaluates the cost-effectiveness of a French telestroke network.MethodsA decision analysis model was built using population-based data. We compared short-term clinical outcomes and costs for the management of acute ischemic stroke patients before and after the implementation of a telestroke network from the point of view of the national health insurance system. Three effectiveness endpoints were used: hospital death, death at 3 months, and severe disability 3 months after stroke (assessed with the modified Rankin scale). Most clinical and economic parameters were estimated fr…

medicine.medical_specialtyTelemedicineCost effectivenessCost-Benefit AnalysisPopulationPilot Projects030204 cardiovascular system & hematologyEfficiency OrganizationalState MedicineDisability Evaluation03 medical and health sciences0302 clinical medicineModified Rankin ScaleHumansMedicineHospital MortalityeducationStrokeTelerehabilitationAcute strokeeducation.field_of_studybusiness.industryHealth PolicyStroke RehabilitationCost-effectiveness analysismedicine.diseaseStrokeModels EconomicEmergency medicineFranceHealth Expendituresbusiness030217 neurology & neurosurgeryDecision analysisInternational Journal of Technology Assessment in Health Care
researchProduct